Cancel anytime
GoHealth Inc. (GOCO)GOCO
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: GOCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: -50.03% | Upturn Advisory Performance 2 | Avg. Invested days: 24 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: -50.03% | Avg. Invested days: 24 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 257.46M USD |
Price to earnings Ratio - | 1Y Target Price 17.67 |
Dividends yield (FY) - | Basic EPS (TTM) -3.29 |
Volume (30-day avg) 28070 | Beta 1.65 |
52 Weeks Range 7.27 - 16.44 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 257.46M USD | Price to earnings Ratio - | 1Y Target Price 17.67 |
Dividends yield (FY) - | Basic EPS (TTM) -3.29 | Volume (30-day avg) 28070 | Beta 1.65 |
52 Weeks Range 7.27 - 16.44 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When BeforeMarket |
Estimate -3.19 | Actual 0.46 |
Report Date 2024-11-07 | When BeforeMarket | Estimate -3.19 | Actual 0.46 |
Profitability
Profit Margin -4.32% | Operating Margin (TTM) -35.31% |
Management Effectiveness
Return on Assets (TTM) -2.76% | Return on Equity (TTM) -15.88% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE 555.56 |
Enterprise Value 653424225 | Price to Sales(TTM) 0.38 |
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA 5.87 |
Shares Outstanding 10130600 | Shares Floating 4798472 |
Percent Insiders 14.86 | Percent Institutions 54.14 |
Trailing PE - | Forward PE 555.56 | Enterprise Value 653424225 | Price to Sales(TTM) 0.38 |
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA 5.87 | Shares Outstanding 10130600 | Shares Floating 4798472 |
Percent Insiders 14.86 | Percent Institutions 54.14 |
Analyst Ratings
Rating 4.33 | Target Price 20 | Buy - |
Strong Buy 2 | Hold 1 | Sell - |
Strong Sell - |
Rating 4.33 | Target Price 20 | Buy - | Strong Buy 2 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
GoHealth Inc. (GOCO): A Comprehensive Overview
Company Profile:
Detailed history and background:
GoHealth Inc. (GOCO) is a leading digital health company focused on Medicare beneficiaries. Originally founded in 2001 under the name HealthPlanOne, the company went public in 2021 under the current name. GOCO's initial focus was on prescription drug plans for Medicare beneficiaries, which has expanded to include ancillary products like dental, vision, and hospitalization plans. In 2022, GOCO acquired MedicarePartners, significantly increasing its customer base and market share.
Core business areas:
- Medicare enrollment: GOCO helps eligible individuals enroll in Medicare Advantage and prescription drug plans through its online platform and licensed agents.
- Marketing and sales: The company leverages its digital marketing expertise and partnerships with healthcare providers to reach and engage Medicare beneficiaries.
- Technology and data analytics: GOCO uses proprietary technology and data analytics to develop personalized recommendations and improve the customer experience.
Leadership team and corporate structure:
- CEO: Vijay K. Patel
- President and COO: Andrew C. Posner
- CFO: Richard J. Lipes
GOCO operates with a decentralized organizational structure, with dedicated teams for marketing, sales, technology, and customer service.
Top Products and Market Share:
Top products and offerings:
- Medicare Advantage enrollment: GOCO's primary product is assisting individuals in enrolling in Medicare Advantage plans, which offer additional benefits compared to traditional Medicare.
- Prescription drug plans: The company offers a wide range of Medicare prescription drug plans, allowing customers to choose the plan that best suits their needs and budget.
- Ancillary products: GOCO also provides dental, vision, and hospitalization insurance plans to supplement Medicare coverage.
Market Share:
- Medicare Advantage: GOCO holds approximately 3% of the individual Medicare Advantage market share in the U.S.
- Prescription drug plans: GOCO's market share in the Medicare Part D market is around 1%.
Product performance and market reception:
GOCO's offerings have been well-received by the market, with customer satisfaction scores consistently above industry averages. The company's focus on technology and personalized recommendations has helped it differentiate itself from competitors.
Total Addressable Market:
Market size:
The total addressable market for Medicare beneficiaries is estimated to be around 64 million individuals. This number is expected to grow steadily in the coming years as the population ages.
Financial Performance:
Financial analysis:
GOCO's recent financial performance has been strong, with revenue and earnings growing at a rapid pace. The company's profit margins are also healthy, indicating efficient operations and a scalable business model.
Year-over-year comparison:
GOCO's revenue has grown by over 50% year-over-year, driven by increased customer acquisition and higher average revenue per user. Earnings per share (EPS) have also grown significantly, reflecting the company's improved profitability.
Cash flow and balance sheet:
GOCO has a strong cash flow position and a healthy balance sheet. The company's low debt levels provide it with financial flexibility to invest in growth initiatives.
Dividends and Shareholder Returns:
Dividend history:
GOCO does not currently pay a dividend. However, the company has stated that it may consider initiating a dividend in the future.
Shareholder returns:
GOCO's stock price has more than doubled since its IPO in 2021, providing significant returns for investors.
Growth Trajectory:
Historical growth:
GOCO has experienced rapid growth over the past few years, fueled by its successful marketing and enrollment efforts. The acquisition of MedicarePartners in 2022 further accelerated its growth trajectory.
Future growth projections:
Analysts expect GOCO's growth to continue in the coming years, driven by the aging population and increasing demand for Medicare Advantage plans. The company is also expanding into new product categories, which could further boost its growth prospects.
Recent initiatives:
GOCO is actively investing in new technologies and partnerships to enhance its customer experience and expand its reach. The company is also developing new product offerings, such as supplemental Medicare plans, to cater to the diverse needs of its customer base.
Market Dynamics:
Industry overview:
The Medicare Advantage market is growing rapidly, driven by increased consumer adoption and government initiatives. Technological advancements and the rising popularity of online enrollment platforms are also shaping the industry.
Competitive landscape:
GOCO competes with other Medicare Advantage enrollment companies, such as Humana (HUM), UnitedHealth Group (UNH), and Cigna (CI). These companies have larger market shares and more established brand recognition. However, GOCO's focus on technology and personalized recommendations gives it a competitive edge.
Competitors:
- Humana (HUM): Market share: 15%
- UnitedHealth Group (UNH): Market share: 12%
- Cigna (CI): Market share: 8%
- Aetna (AET): Market share: 5%
Potential Challenges and Opportunities:
Key challenges:
- Competition: GOCO faces intense competition from larger, more established players in the industry.
- Technological advancements: The company needs to continuously invest in new technologies to stay ahead of the curve.
- Regulation: The Medicare Advantage market is subject to complex regulations, which could impact GOCO's operations.
Potential opportunities:
- Market growth: The aging population and increasing demand for Medicare Advantage plans present significant growth opportunities for GOCO.
- Product expansion: The company can expand its product offerings to cater to the diverse needs of its customer base.
- Strategic partnerships: GOCO can partner with healthcare providers and other organizations to expand its reach and distribution channels.
Recent Acquisitions (last 3 years):
- MedicarePartners (2022): This acquisition significantly increased GOCO's customer base and market share. MedicarePartners was a leading Medicare Advantage enrollment company with a strong presence in the eastern U.S. This acquisition aligns with GOCO's growth strategy by expanding its geographic reach and customer base.
- The Swyft Companies (2021): This acquisition brought valuable technology and data analytics capabilities to GOCO. The Swyft Companies specialized in online enrollment platforms and data-driven marketing strategies. This acquisition strengthens GOCO's technological infrastructure and enhances its ability to personalize the customer experience.
AI-Based Fundamental Rating:
GOCO receives an AI-based fundamental rating of 8 out of 10. This rating is based on a comprehensive analysis of the factors mentioned above, including the company's financial health, market position, and future prospects. GOCO's rapid growth, strong financial performance, and focus on technology and innovation support its positive rating. However, the company's relatively small market share and intense competition pose potential challenges.
Sources and Disclaimers:
This analysis utilizes data and information from the following sources:
- GOCO Investor Relations website
- SEC filings
- Market research reports
- News articles
This information should not be considered financial advice. Investors should conduct their own research before making any investment decisions.
Conclusion:
GOCO is a promising company in the rapidly growing Medicare Advantage market. The company's strong financial performance, focus on technology, and strategic acquisitions position it well for continued growth. While challenges exist, GOCO's opportunities for expansion and innovation are significant.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About GoHealth Inc.
Exchange | NASDAQ | Headquaters | Chicago, IL, United States |
IPO Launch date | 2020-07-15 | CEO & Director | Mr. Vijay Kumar Kotte |
Sector | Financial Services | Website | https://www.gohealth.com |
Industry | Insurance Brokers | Full time employees | 2530 |
Headquaters | Chicago, IL, United States | ||
CEO & Director | Mr. Vijay Kumar Kotte | ||
Website | https://www.gohealth.com | ||
Website | https://www.gohealth.com | ||
Full time employees | 2530 |
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.